19 Apr, 2022
We are one of the largest vaccine companies in the world, producing vaccines that protect people at all stages of life. In our research and development, we focus on the development of vaccines against infectious diseases that have a high unmet medical need and great market potential. Our vaccines business has a portfolio of more than 20 vaccines that protect people from a multitude of diseases throughout their lives. We deliver these vaccines to people in over 160 countries. There are 17 vaccine candidates in development in FY2020, including three for the prevention of respiratory syncytial virus (RSV). In October 2017, our shingles vaccine, Shingrix, received regulatory approval in Canada and the United States. In 2020, the company had a turnover of £7 billion. Our strategy is to make differentiated and high-quality vaccines available to as many people as possible. To achieve this, we are focused on...
Biochemicals / Pharmaceuticals
GSK Marburg, Germany Plant Manager